Učitavanje...
HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice
HER2 is overexpressed in approximately 10%-20% of gastric and gastroesophageal junction carcinomas. In these types of cancer, accurate assessment of HER2 status is mandatory, for selecting patients who may benefit from targeted therapies with anti-HER2 drugs such as Trastuzumab. This manuscript focu...
Spremljeno u:
| Izdano u: | World J Gastroenterol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4948273/ https://ncbi.nlm.nih.gov/pubmed/27468182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i26.5879 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|